203 related articles for article (PubMed ID: 26670597)
1. Comprehensively understanding fatigue in patients with myeloproliferative neoplasms.
Scherber RM; Kosiorek HE; Senyak Z; Dueck AC; Clark MM; Boxer MA; Geyer HL; McCallister A; Cotter M; Van Husen B; Harrison CN; Mesa RA
Cancer; 2016 Feb; 122(3):477-85. PubMed ID: 26670597
[TBL] [Abstract][Full Text] [Related]
2. Depressive symptoms and myeloproliferative neoplasms: Understanding the confounding factor in a complex condition.
Padrnos L; Scherber R; Geyer H; Langlais BT; Dueck AC; Kosiorek HE; Senyak Z; Clark M; Boxer M; Cotter M; Harrison C; Stonnington C; Geda Y; Mesa R
Cancer Med; 2020 Nov; 9(22):8301-8309. PubMed ID: 32976697
[TBL] [Abstract][Full Text] [Related]
3. Allodynia in migraine: association with comorbid pain conditions.
Tietjen GE; Brandes JL; Peterlin BL; Eloff A; Dafer RM; Stein MR; Drexler E; Martin VT; Hutchinson S; Aurora SK; Recober A; Herial NA; Utley C; White L; Khuder SA
Headache; 2009 Oct; 49(9):1333-44. PubMed ID: 19788473
[TBL] [Abstract][Full Text] [Related]
4. Mood and Anxiety Disorders in Chronic Fatigue Syndrome, Fibromyalgia, and Irritable Bowel Syndrome: Results From the LifeLines Cohort Study.
Janssens KA; Zijlema WL; Joustra ML; Rosmalen JG
Psychosom Med; 2015 May; 77(4):449-57. PubMed ID: 25768845
[TBL] [Abstract][Full Text] [Related]
5. Self-Reported Migraine and Chronic Fatigue Syndrome Are More Prevalent in People with Myofascial vs Nonmyofascial Temporomandibular Disorders.
Dahan H; Shir Y; Nicolau B; Keith D; Allison P
J Oral Facial Pain Headache; 2016; 30(1):7-13. PubMed ID: 26817027
[TBL] [Abstract][Full Text] [Related]
6. Interstitial cystitis/painful bladder syndrome and associated medical conditions with an emphasis on irritable bowel syndrome, fibromyalgia and chronic fatigue syndrome.
Nickel JC; Tripp DA; Pontari M; Moldwin R; Mayer R; Carr LK; Doggweiler R; Yang CC; Mishra N; Nordling J
J Urol; 2010 Oct; 184(4):1358-63. PubMed ID: 20719340
[TBL] [Abstract][Full Text] [Related]
7. The role of sexuality symptoms in myeloproliferative neoplasm symptom burden and quality of life: An analysis by the MPN QOL International Study Group.
Geyer HL; Andreasson B; Kosiorek HE; Dueck AC; Scherber RM; Martin KA; Butler KA; Harrison CN; Radia DH; Cervantes F; Kiladjian JJ; Reiter A; Birgegard G; Passamonti F; Senyak Z; Vannucchi AM; Paoli C; Xiao Z; Samuelsson J; Mesa RA
Cancer; 2016 Jun; 122(12):1888-96. PubMed ID: 27070130
[TBL] [Abstract][Full Text] [Related]
8. The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients.
Mesa RA; Niblack J; Wadleigh M; Verstovsek S; Camoriano J; Barnes S; Tan AD; Atherton PJ; Sloan JA; Tefferi A
Cancer; 2007 Jan; 109(1):68-76. PubMed ID: 17123268
[TBL] [Abstract][Full Text] [Related]
9. Tobacco use in the Myeloproliferative neoplasms: symptom burden, patient opinions, and care.
Christensen SF; Scherber RM; Mazza GL; Dueck AC; Brochmann N; Andersen CL; Hasselbalch HC; Mesa RA; Geyer HL
BMC Cancer; 2021 Jun; 21(1):691. PubMed ID: 34112113
[TBL] [Abstract][Full Text] [Related]
10. [Impact of the fibromyalgia in the chronic fatigue syndrome].
Faro M; Sáez-Francàs N; Castro-Marrero J; Aliste L; Collado A; Alegre J
Med Clin (Barc); 2014 Jun; 142(12):519-25. PubMed ID: 24387955
[TBL] [Abstract][Full Text] [Related]
11. Restless legs syndrome, sleep impairment, and fatigue in chronic obstructive pulmonary disease.
Cavalcante AG; de Bruin PF; de Bruin VM; Pereira ED; Cavalcante MM; Nunes DM; Viana CS
Sleep Med; 2012 Aug; 13(7):842-7. PubMed ID: 22727926
[TBL] [Abstract][Full Text] [Related]
12. Impact of Myeloproliferative neoplasms on patients' employment status and work productivity in the United States: results from the living with MPNs survey.
Yu J; Parasuraman S; Paranagama D; Bai A; Naim A; Dubinski D; Mesa R
BMC Cancer; 2018 Apr; 18(1):420. PubMed ID: 29653557
[TBL] [Abstract][Full Text] [Related]
13. Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group.
Geyer HL; Kosiorek H; Dueck AC; Scherber R; Slot S; Zweegman S; Te Boekhorst PA; Senyak Z; Schouten HC; Sackmann F; Fuentes AK; Hernández-Maraver D; Pahl HL; Griesshammer M; Stegelmann F; Döhner K; Lehmann T; Bonatz K; Reiter A; Boyer F; Etienne G; Ianotto JC; Ranta D; Roy L; Cahn JY; Harrison CN; Radia D; Muxi P; Maldonado N; Besses C; Cervantes F; Johansson PL; Barbui T; Barosi G; Vannucchi AM; Paoli C; Passamonti F; Andreasson B; Ferrari ML; Rambaldi A; Samuelsson J; Cannon K; Birgegard G; Xiao Z; Xu Z; Zhang Y; Sun X; Xu J; Kiladjian JJ; Zhang P; Gale RP; Mesa RA
Haematologica; 2017 Jan; 102(1):85-93. PubMed ID: 27540137
[TBL] [Abstract][Full Text] [Related]
14. Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey.
Mesa R; Miller CB; Thyne M; Mangan J; Goldberger S; Fazal S; Ma X; Wilson W; Paranagama DC; Dubinski DG; Boyle J; Mascarenhas JO
BMC Cancer; 2016 Feb; 16():167. PubMed ID: 26922064
[TBL] [Abstract][Full Text] [Related]
15. The relationship with restless legs syndrome, fibromyalgia, and depressive symptoms in migraine patients.
Akdag Uzun Z; Kurt S; Karaer Unaldi H
Neurol Sci; 2018 Aug; 39(8):1409-1414. PubMed ID: 29777478
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of restless legs syndrome in fibromyalgia syndrome: an analysis of quality of sleep and life.
Civelek GM; Ciftkaya PO; Karatas M
J Back Musculoskelet Rehabil; 2014; 27(4):537-44. PubMed ID: 24867908
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of restless legs syndrome among women with multi-site pain: a population-based study in Dalarna, Sweden.
Stehlik R; Ulfberg J; Hedner J; Grote L
Eur J Pain; 2014 Nov; 18(10):1402-9. PubMed ID: 24700622
[TBL] [Abstract][Full Text] [Related]
18. Intra- and Inter-Patient Symptom Variability in Fibromyalgia: Results of a 90-Day Assessment.
Toussaint L; Vincent A; McAllister SJ; Whipple M
Musculoskeletal Care; 2015 Jun; 13(2):93-100. PubMed ID: 25408116
[TBL] [Abstract][Full Text] [Related]
19. The Myeloproliferative Neoplasm Symptom Assessment Form (MPN-SAF): international prospective validation and reliability trial in 402 patients.
Scherber R; Dueck AC; Johansson P; Barbui T; Barosi G; Vannucchi AM; Passamonti F; Andreasson B; Ferarri ML; Rambaldi A; Samuelsson J; Birgegard G; Tefferi A; Harrison CN; Radia D; Mesa RA
Blood; 2011 Jul; 118(2):401-8. PubMed ID: 21536863
[TBL] [Abstract][Full Text] [Related]
20. The SIMM study: Survey of integrative medicine in myeloproliferative neoplasms.
Gowin K; Langlais BT; Kosiorek HE; Dueck A; Millstine D; Huberty J; Eckert R; Mesa RA
Cancer Med; 2020 Dec; 9(24):9445-9453. PubMed ID: 33140580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
